Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients

Clinical trial NCT06778538 · COMPLETED

Trial details

NCT number: NCT06778538
Sponsor: Shang Panfeng
Status: COMPLETED
Study type: OBSERVATIONAL

Clear Cell Renal Cell Carcinoma (ccRCC)

Start date: 2024-07-01
Primary completion: 2024-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.